Annual Working Capital
$161.19 M
+$98.64 M+157.68%
December 31, 2024
Summary
- As of March 13, 2025, TARA annual working capital is $161.19 million, with the most recent change of +$98.64 million (+157.68%) on December 31, 2024.
- During the last 3 years, TARA annual working capital has risen by +$72.38 million (+81.50%).
- TARA annual working capital is now -3.20% below its all-time high of $166.52 million, reached on December 31, 2020.
Performance
TARA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$161.19 M
+$84.75 M+110.88%
December 1, 2024
Summary
- As of March 13, 2025, TARA quarterly working capital is $161.19 million, with the most recent change of +$84.75 million (+110.88%) on December 1, 2024.
- Over the past year, TARA quarterly working capital has increased by +$98.64 million (+157.68%).
- TARA quarterly working capital is now -3.20% below its all-time high of $166.52 million, reached on December 31, 2020.
Performance
TARA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TARA Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +157.7% | +157.7% |
3 y3 years | +81.5% | +126.9% |
5 y5 years | +6330.9% | +126.9% |
TARA Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +157.7% | at high | +207.6% |
5 y | 5-year | -3.2% | +6330.9% | -3.2% | +6330.9% |
alltime | all time | -3.2% | +6330.9% | -3.2% | +6330.9% |
Protara Therapeutics Working Capital History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $161.19 M(+157.7%) | - |
Dec 2024 | - | $161.19 M(+110.9%) |
Sep 2024 | - | $76.44 M(-11.7%) |
Jun 2024 | - | $86.57 M(+65.2%) |
Mar 2024 | - | $52.41 M(-16.2%) |
Dec 2023 | $62.56 M(-22.2%) | $62.56 M(-11.9%) |
Sep 2023 | - | $71.04 M(-10.5%) |
Jun 2023 | - | $79.33 M(-10.1%) |
Mar 2023 | - | $88.21 M(+9.7%) |
Dec 2022 | $80.41 M | $80.41 M(-15.3%) |
Sep 2022 | - | $94.96 M(-2.7%) |
Jun 2022 | - | $97.60 M(+11.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $87.83 M(-1.1%) |
Dec 2021 | $88.81 M(-46.7%) | $88.81 M(-3.5%) |
Sep 2021 | - | $92.01 M(+9.3%) |
Jun 2021 | - | $84.15 M(-0.3%) |
Mar 2021 | - | $84.38 M(-49.3%) |
Dec 2020 | $166.52 M(-6536.8%) | $166.52 M(+2.0%) |
Sep 2020 | - | $163.23 M(+455.1%) |
Jun 2020 | - | $29.40 M(-15.3%) |
Mar 2020 | - | $34.71 M(-1441.9%) |
Dec 2019 | -$2.59 M(-112.8%) | -$2.59 M(-106.3%) |
Sep 2019 | - | $41.22 M |
Dec 2018 | $20.16 M | - |
FAQ
- What is Protara Therapeutics annual working capital?
- What is the all time high annual working capital for Protara Therapeutics?
- What is Protara Therapeutics annual working capital year-on-year change?
- What is Protara Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Protara Therapeutics?
- What is Protara Therapeutics quarterly working capital year-on-year change?
What is Protara Therapeutics annual working capital?
The current annual working capital of TARA is $161.19 M
What is the all time high annual working capital for Protara Therapeutics?
Protara Therapeutics all-time high annual working capital is $166.52 M
What is Protara Therapeutics annual working capital year-on-year change?
Over the past year, TARA annual working capital has changed by +$98.64 M (+157.68%)
What is Protara Therapeutics quarterly working capital?
The current quarterly working capital of TARA is $161.19 M
What is the all time high quarterly working capital for Protara Therapeutics?
Protara Therapeutics all-time high quarterly working capital is $166.52 M
What is Protara Therapeutics quarterly working capital year-on-year change?
Over the past year, TARA quarterly working capital has changed by +$98.64 M (+157.68%)